REQUEST A DEMO
Total
USD $0.00
Search more companies

Nvo Immunoteh AO (Нво Иммунотех АО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Nvo Immunoteh AO Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Nvo Immunoteh AO (Нво Иммунотех АО) is a company based in Russia, with its head office in Moscow. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on November 18, 2002. It currently has a total number of 12 (2022) employees. In 2024, the company reported a net sales revenue drop of 2.47%. A negative growth of 1.32% was recorded in its total assets. In 2024, Nvo Immunoteh AO (Нво Иммунотех АО)’s net profit margin increased by 7.71%.

Headquarters
1, 75-B
Moscow; Moscow; Postal Code: 119234

Contact Details: Purchase the Nvo Immunoteh AO (Нво Иммунотех АО) report to view the information.

Basic Information
Total Employees:
Purchase the Nvo Immunoteh AO (Нво Иммунотех АО) report to view the information.
Registered Capital:
Purchase the Nvo Immunoteh AO (Нво Иммунотех АО) report to view the information.
Financial Auditors:
Purchase the Nvo Immunoteh AO (Нво Иммунотех АО) report to view the information.
Incorporation Date:
November 18, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Subsidiaries
Npc Prodkartofeli AO
3%
Company Performance
Financial values in the chart are available after Nvo Immunoteh AO (Нво Иммунотех АО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-2.47%
Total operating revenue
-2.47%
Operating profit (EBIT)
92.16%
Net Profit (Loss) for the Period
65.32%
Total Assets
-1.32%
Total Equity
-0.02%
Operating Profit Margin (ROS)
3.56%
Net Profit Margin
7.71%
Return on Equity (ROE)
4.96%
Quick Ratio
9.42%
Cash Ratio
8.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?